Genflow Biosciences plc (GENFF)
OTCMKTS · Delayed Price · Currency is USD
0.0150
0.00 (0.00%)
Aug 22, 2025, 4:00 PM EDT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of $3.97 million as of August 27, 2025. Its market cap has decreased by -61.52% in one year.
Market Cap
3.97M
Enterprise Value
3.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 45.94M to 3.97M, a decrease of -91.35%. That is a compound annual growth rate of -49.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 4.58M | -39.33% |
| Dec 31, 2024 | 7.55M | 42.24% |
| Dec 29, 2023 | 5.31M | -37.23% |
| Dec 30, 2022 | 8.46M | -81.59% |
| Jan 17, 2022 | 45.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |